Myomo Inc., a Cambridge medical robotics company founded in 2004, has opened a crowdfunding campaign through the online brokerage Banq.co to help it sell shares in an initial public offering. Read more >>
Spectra7 Microsystems Inc., a leading provider of high-performance analog semiconductor products for virtual reality (VR), augmented reality (AR), data center and other connectivity markets today announced its collaboration with eSight Corporation. Read more >>
Every Saskatchewan Rush play is an eye-opening experience for Bobbi Janzen.
The legally blind Saskatoon woman has watched every Rush home game this season thanks to pair of eSight glasses she fundraised for last year.
“It’s amazing. These are things I didn’t even know existed — from down to the net to the lacrosse sticks themselves, the ball,” Janzen said. “I hadn’t seen a ball in motion in my life, so putting those glasses on and seeing these things, reading jerseys, […]
With the support of Ergoresearch, Équilibre—the largest network of orthotists in Quebec , announces the adoption of the latest cutting-edge technology in the management of knee pain: KneeKGTM, which expands the evaluation services it offers in its clinics and knee centres. Read more >>
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) („Corbus” or the „Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today its financial results for the year ended December 31, 2016. Read more >>
Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the publication of new preclinical data describing its novel ST1 antibodies targeting, with high affinity and specificity, the Sialyl-Thomasen-nouveau antigen (STn), a tumor-associated carbohydrate antigen (TACA). Read more >>
Corbus Pharmaceuticals to Present Gene Expression Data from Recent Phase 2 Systemic Sclerosis Study Demonstrating JBT-101 Inhibits Inflammation and Fibrosis PathwaysZiad
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical stage drug development company targeting rare, chronic, serious inflammatory and fibrotic diseases, announced today that Michael L. Whitfield, Ph.D., Professor of Molecular and Systems Biology, Dartmouth Geisel School of Medicine and Scientific Founder of Celdara Medical, LLC, will present data demonstrating JBT-101 treatment of systemic sclerosis patients inhibits gene expression of key regulatory proteins in molecular pathways associated with activating inflammation and fibrosis, while increasing gene expression […]
Olivia Lettich had been to a Calgary Flames game before, but she watched one for the very first time Sunday.
The 11-year-old is legally blind, but thanks to eSight she was able to take in the sounds, and sights, of her favorite hockey team. Read more >>
Forget virtual reality; Christian Cardenas is seeing in actual reality for the first time.
“I can see you,” Christian told Jeff Fenton, marketing director for eSight, as he turned on Christian’s new eSight glasses. Christian was not shy about telling everyone Friday morning he could see them, and it was not just their shapes and voices registering. He was seeing them for the first time.
Read more >>